Tag: matica biotechnology

matica biotechnology

Latest News

CHA Biotech's U.S. arm launches CDMO platform, bags first client

New manufacturing system shortens gene therapy development timelines and improves client collaboration.

2026.6.17

Matica Biotechnology's plant in College Station, Texas [CHA BIOTECH]

Cha Biotech's U.S. CDMO arm inks vector deal with Cirsium

Matica Biotechnology, the U.S. contract development and manufacturing organization arm of Cha Biotech, announced Tuesday that it signed an agreement with Cirsium Biosciences to produce the California-based firm's vectors.

2025.9.9

Most popular

From left: Laura Parks, executive vice president of commercial operations at Matica Biotechnology; Heather N. Sugrue, vice president of alliance management [CHA BIOTECH]

U.S. subsidiary of CHA Biotech appoints new executives

Matica Biotechnology, a US subsidiary of CHA Biotech, has appointed Laura Parks as EVP of commercial operations and Heather Sugrue as VP of alliance management to enhance its cell and gene therapy contract manufacturing capabilities.

2023.9.19

Matica Biotechnology, a U.S. subsidiary of CHA Biotech, introduced the MatiMax cell line at the Bio International Convention 2023, or BIO USA, in Boston. [CHA BIOTECH]

Matica Biotechnology introduces self-developed cell line

Matica Biotechnology, a U.S. subsidiary of CHA Biotech, introduced its self-developed cell line MatiMax at the annual BIO International Convention 2023 (BIO USA) taking place in Boston.

2023.6.7

Matica Biotechnology and German bio company Sartorius collaborate to develop real-time process analysis technology and an automation system. [CHA BIOTECH]

CHA Biotech sees big future in CDMO market

As global pharmaceutical and bio groups increase the outsourcing of production in the contract development and manufacturing organization (CDMO) market, CHA Biotech is focusing on innovation in the cell and gene treatment manufacturing sector.

2022.12.20

Matica to work with Germany's Sartorius on viral vector production

Matica Biotechnology, a wholly owned subsidiary of CHA Biotech, signed an agreement with Göttingen, Germany’s Sartorius, to cooperate on developing advanced technologies for large-scale viral vector production.

2021.10.19

Tag: matica biotechnology

matica biotechnology

Latest News

CHA Biotech's U.S. arm launches CDMO platform, bags first client

Cha Biotech's U.S. CDMO arm inks vector deal with Cirsium

Most popular

179 dead after Jeju Air flight 7C2216 crashes at Muan International Airport — as it happened

[단독] 삼성SDI 전고체 배터리, 2027년 양산 순항…휴머노이드·모바일까지 확장

Was Son Heung-min benched over media boycott? Whistleblower claims squad rift cost Korea at World Cup.

Ex-football manager Hong Myung-bo leaves for U.S., says his story 'will come out someday'

BigHit Music's new boy band Cortis showcase debut tracks — as it happened

U.S. subsidiary of CHA Biotech appoints new executives

Matica Biotechnology introduces self-developed cell line

CHA Biotech sees big future in CDMO market

Matica to work with Germany's Sartorius on viral vector production